Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
168 | 21544 | 41.1 | 81% |
Classes in level above (level 3) |
Classes in level below (level 1) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ASYMMETRIC DIMETHYLARGININE | Author keyword | 492 | 67% | 2% | 440 |
2 | ENDOTHELIUM | Author keyword | 399 | 16% | 10% | 2258 |
3 | ADMA | Author keyword | 298 | 68% | 1% | 262 |
4 | ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR | Author keyword | 243 | 60% | 1% | 265 |
5 | DIMETHYLARGININE DIMETHYLAMINOHYDROLASE | Author keyword | 201 | 86% | 0% | 101 |
6 | NADPH OXIDASE | Author keyword | 185 | 23% | 3% | 713 |
7 | EDHF | Author keyword | 162 | 59% | 1% | 182 |
8 | ENDOTHELIAL FUNCTION | Author keyword | 130 | 19% | 3% | 637 |
9 | ENDOTHELIAL DYSFUNCTION | Author keyword | 125 | 18% | 3% | 637 |
10 | ENDOTHELIUM DERIVED RELAXING FACTOR | Author keyword | 116 | 32% | 1% | 303 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ASYMMETRIC DIMETHYLARGININE | 492 | 67% | 2% | 440 | Search ASYMMETRIC+DIMETHYLARGININE | Search ASYMMETRIC+DIMETHYLARGININE |
2 | ENDOTHELIUM | 399 | 16% | 10% | 2258 | Search ENDOTHELIUM | Search ENDOTHELIUM |
3 | ADMA | 298 | 68% | 1% | 262 | Search ADMA | Search ADMA |
4 | ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR | 243 | 60% | 1% | 265 | Search ENDOTHELIUM+DERIVED+HYPERPOLARIZING+FACTOR | Search ENDOTHELIUM+DERIVED+HYPERPOLARIZING+FACTOR |
5 | DIMETHYLARGININE DIMETHYLAMINOHYDROLASE | 201 | 86% | 0% | 101 | Search DIMETHYLARGININE+DIMETHYLAMINOHYDROLASE | Search DIMETHYLARGININE+DIMETHYLAMINOHYDROLASE |
6 | NADPH OXIDASE | 185 | 23% | 3% | 713 | Search NADPH+OXIDASE | Search NADPH+OXIDASE |
7 | EDHF | 162 | 59% | 1% | 182 | Search EDHF | Search EDHF |
8 | ENDOTHELIAL FUNCTION | 130 | 19% | 3% | 637 | Search ENDOTHELIAL+FUNCTION | Search ENDOTHELIAL+FUNCTION |
9 | ENDOTHELIAL DYSFUNCTION | 125 | 18% | 3% | 637 | Search ENDOTHELIAL+DYSFUNCTION | Search ENDOTHELIAL+DYSFUNCTION |
10 | ENDOTHELIUM DERIVED RELAXING FACTOR | 116 | 32% | 1% | 303 | Search ENDOTHELIUM+DERIVED+RELAXING+FACTOR | Search ENDOTHELIUM+DERIVED+RELAXING+FACTOR |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ADMA | 455 | 79% | 1% | 292 |
2 | DIMETHYLAMINOHYDROLASE | 425 | 84% | 1% | 235 |
3 | RELAXING FACTOR | 366 | 21% | 7% | 1590 |
4 | HYPERPOLARIZING FACTOR | 352 | 48% | 3% | 543 |
5 | BRACHIAL ARTERY | 317 | 39% | 3% | 635 |
6 | RESISTANCE ARTERIES | 266 | 37% | 3% | 570 |
7 | VASODILATION | 250 | 24% | 4% | 932 |
8 | ASYMMETRIC DIMETHYLARGININE | 240 | 43% | 2% | 424 |
9 | DEPENDENT RELAXATION | 217 | 39% | 2% | 436 |
10 | ENDOTHELIAL DYSFUNCTION | 190 | 14% | 6% | 1266 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | JOURNAL OF VASCULAR RESEARCH | 35 | 17% | 1% | 192 |
2 | MICROCIRCULATION | 26 | 15% | 1% | 153 |
3 | BLOOD VESSELS | 26 | 24% | 0% | 95 |
4 | ENDOTHELIUM-JOURNAL OF ENDOTHELIAL CELL RESEARCH | 6 | 13% | 0% | 42 |
5 | MICROCIRCULATION ENDOTHELIUM AND LYMPHATICS | 2 | 11% | 0% | 20 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The NOX family of ROS-generating NADPH oxidases: Physiology and pathophysiology | 2007 | 2000 | 910 | 26% |
Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement | 2015 | 7 | 179 | 61% |
Endothelial dysfunction in cardiovascular diseases - The role of oxidant stress | 2000 | 1929 | 45 | 67% |
Assessment of flow-mediated dilation in humans: a methodological and physiological guideline | 2011 | 198 | 120 | 76% |
Biochemistry, Physiology, and Pathophysiology of NADPH Oxidases in the Cardiovascular System | 2012 | 162 | 377 | 65% |
L-Homoarginine and cardiovascular disease | 2015 | 7 | 26 | 50% |
Homoarginine in the renal and cardiovascular systems | 2015 | 6 | 61 | 56% |
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets | 2011 | 221 | 219 | 59% |
Nox enzymes and the biology of reactive oxygen | 2004 | 1407 | 60 | 38% |
NAD(P)H oxidase - Role in cardiovascular biology and disease | 2000 | 1874 | 86 | 48% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PHYSIOL MORPHOL | 83 | 64% | 0.4% | 82 |
2 | HUMAN VASC CONTROL | 44 | 100% | 0.1% | 16 |
3 | ROCKIES FDN | 33 | 100% | 0.1% | 13 |
4 | HUMAN CARDIOVASC PHYSIOL | 30 | 84% | 0.1% | 16 |
5 | DALTON CARDIOVASC | 25 | 16% | 0.7% | 142 |
6 | KARDIOVASKULARE PHYSIOL | 20 | 40% | 0.2% | 40 |
7 | MICROVASC BIOL GRP | 15 | 67% | 0.1% | 14 |
8 | SMOOTH MUSCLE PROGRAMME | 15 | 77% | 0.0% | 10 |
9 | MED PHARMACOL PHYSIOL | 14 | 13% | 0.5% | 102 |
10 | MULTIDISCIPLINARY GRP HYPERTENS | 11 | 28% | 0.2% | 33 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000016895 | PLATONIN//CORONARY BLOOD FLOW//CORONARY CIRCULATION |
2 | 0.0000012812 | RHO KINASE//FASUDIL//CALDESMON |
3 | 0.0000011238 | TUBULOGLOMERULAR FEEDBACK//SALT SENSITIVITY//AFFERENT ARTERIOLE |
4 | 0.0000011060 | ENDOTHELIN//ENDOTHELIN 1//ENDOTHELIN RECEPTORS |
5 | 0.0000010649 | WALL SHEAR STRESS//SHEAR STRESS//CAROTID BIFURCATION |
6 | 0.0000010511 | NITRIC OXIDE//PEROXYNITRITE//NITRIC OXIDE-BIOLOGY AND CHEMISTRY |
7 | 0.0000010333 | SOLUBLE EPOXIDE HYDROLASE//EPOXYEICOSATRIENOIC ACIDS//EPOXIDE HYDROLASE |
8 | 0.0000009083 | NITRATE TOLERANCE//NITROGLYCERIN//ORGANIC NITRATES |
9 | 0.0000007809 | RESTENOSIS//INTRAVASCULAR BRACHYTHERAPY//TRANILAST |
10 | 0.0000007340 | INTIMA MEDIA THICKNESS//CAROTID ARTERIES//VASA VASORUM |